Cohen & Steers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-5,500
| Closed | -$139K | – | 468 |
|
|
2025
Q1 | $139K | Buy |
+5,500
| New | +$144K | ﹤0.01% | 357 |
|
|
2024
Q4 | – | Sell |
-3,945
| Closed | -$114K | – | 436 |
|
|
2024
Q3 | $114K | Buy |
3,945
+75
| +2% | +$2.19K | ﹤0.01% | 358 |
|
|
2024
Q2 | $108K | Buy |
3,870
+1,655
| +75% | +$45.6K | ﹤0.01% | 355 |
|
|
2024
Q1 | $61K | Hold |
2,215
| – | – | ﹤0.01% | 352 |
|
|
2023
Q4 | $64K | Hold |
2,215
| – | – | ﹤0.01% | 355 |
|
|
2023
Q3 | $73K | Hold |
2,215
| – | – | ﹤0.01% | 348 |
|
|
2023
Q2 | $81K | Hold |
2,215
| – | – | ﹤0.01% | 351 |
|
|
2023
Q1 | $90K | Hold |
2,215
| – | – | ﹤0.01% | 354 |
|
|
2022
Q4 | $113K | Hold |
2,215
| – | – | ﹤0.01% | 353 |
|
|
2022
Q3 | $97K | Hold |
2,215
| – | – | ﹤0.01% | 357 |
|
|
2022
Q2 | $116K | Sell |
2,215
-1,308
| -37% | -$66.7K | ﹤0.01% | 358 |
|
|
2022
Q1 | $182K | Hold |
3,523
| – | – | ﹤0.01% | 332 |
|
|
2021
Q4 | $208K | Sell |
3,523
-14,130
| -80% | -$700K | ﹤0.01% | 329 |
|
|
2021
Q3 | $759K | Buy |
17,653
+9,489
| +116% | +$420K | ﹤0.01% | 262 |
|
|
2021
Q2 | $320K | Hold |
8,164
| – | – | ﹤0.01% | 303 |
|
|
2021
Q1 | $296K | Sell |
8,164
-407
| -5% | -$14.5K | ﹤0.01% | 309 |
|
|
2020
Q4 | $315K | Sell |
8,571
-463
| -5% | -$17K | ﹤0.01% | 302 |
|
|
2020
Q3 | $315K | Buy |
+9,034
| New | +$317K | ﹤0.01% | 291 |
|
|
2018
Q2 | – | Sell |
-46,465
| Closed | -$1.56M | – | 457 |
|
|
2018
Q1 | $1.56M | Sell |
46,465
-680,129
| -94% | -$23.4M | ﹤0.01% | 338 |
|
|
2017
Q4 | $25M | Sell |
726,594
-6,023
| -0.8% | -$205K | 0.07% | 115 |
|
|
2017
Q3 | $24.8M | Buy |
732,617
+57,682
| +9% | +$1.85M | 0.07% | 112 |
|
|
2017
Q2 | $21.5M | Hold |
674,935
| – | – | 0.06% | 132 |
|
|
2017
Q1 | $21.9M | Sell |
674,935
-90,761
| -12% | -$2.86M | 0.06% | 135 |
|
|
2016
Q4 | $23.6M | Sell |
765,696
-29,134
| -4% | -$889K | 0.07% | 126 |
|
|
2016
Q3 | $25.5M | Sell |
794,830
-4,882
| -0.6% | -$163K | 0.07% | 117 |
|
|
2016
Q2 | $26.7M | Buy |
799,712
+240,354
| +43% | +$7.67M | 0.07% | 108 |
|
|
2016
Q1 | $15.7M | Buy |
559,358
+66,929
| +14% | +$1.91M | 0.04% | 141 |
|
|
2015
Q4 | $15.1M | Buy |
+492,429
| New | +$15.5M | 0.04% | 128 |
|
|
2015
Q2 | – | Sell |
-407,125
| Closed | -$13.4M | – | 471 |
|
|
2015
Q1 | $13.4M | Buy |
407,125
+96,019
| +31% | +$3.05M | 0.04% | 187 |
|
|
2014
Q4 | $9.19M | Sell |
311,106
-601,623
| -66% | -$17.3M | 0.03% | 217 |
|
|
2014
Q3 | $25.6M | Buy |
912,729
+127,112
| +16% | +$3.57M | 0.08% | 120 |
|
|
2014
Q2 | $22.1M | Sell |
785,617
-106,559
| -12% | -$3.04M | 0.06% | 158 |
|
|
2014
Q1 | $27.2M | Sell |
892,176
-194,674
| -18% | -$5.8M | 0.08% | 130 |
|
|
2013
Q4 | $31.6M | Sell |
1,086,850
-694,270
| -39% | -$20.2M | 0.1% | 128 |
|
|
2013
Q3 | $48.5M | Sell |
1,781,120
-427,836
| -19% | -$11.6M | 0.16% | 98 |
|
|
2013
Q2 | $58.7M | Buy |
+2,208,956
| New | +$61M | 0.18% | 93 |
|
Other funds holding PFE
Cohen & Steers's PFE Position: Q2 2025 in Review
Cohen & Steers sold out of Pfizer (PFE) in Q2 2025, closing a stake of 5,500 shares — an estimated $139K sold.
Cohen & Steers first reported a position in PFE in Q2 2013 and held it in 36 quarters. The position peaked at $58.7M in Q2 2013. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Cohen & Steers reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Cohen & Steers sold 5,500 Pfizer shares in Q2 2025, an estimated $139K.
- Cohen & Steers first reported a position in Pfizer in Q2 2013 and held it in 36 quarters.
- Cohen & Steers's Pfizer position peaked at $58.7M in Q2 2013.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Cohen & Steers's 13F filing for Q2 2025, filed 14 Aug 2025.